Table 2.
Studies reporting the efficacy of single- and multi-walled CNTs conjugated with compounds displaying antimicrobial activity
CNT-antimicrobial compounds | Type | Medical application | Species | Major conclusions | Reference |
---|---|---|---|---|---|
Antimicrobial agents | |||||
Cefalexin | MWCNT | Nonspecified |
B. subtilis E. coli P. aeruginosa S. aureus |
MWCNT/cefalexin films reduced bacteria viability by 50%–80% | (Qi et al., 2012) |
AZ | SWCNT | Drug delivery | M. luteus | SWCNT/AZ composites had a significant in vitro activity against M. luteus (p < 0.05) | (Darabi et al., 2014) |
Rifampicin | MWCNT | Implant materials | S. epidermidis | MWCNT/rifampicin-coated surfaces caused a significant inhibition of biofilm formation for up to 5 days (50%) | (Hirschfeld et al., 2017) |
Photosensitizers | |||||
APT | SWCNT | Nonspecified | S. aureus | A high reduction of bacterial growth (≈90%) was observed when bacteria were exposed to porphyrin-SWCNT composite | (Sah et al., 2018) |
DTTC fluorophores | MWCNT | Nonspecified |
P. aeruginosa S. aureus |
P. aeruginosa exposed to MWNT/DTTC hybrid films and irradiated with NIR laser light were inactivated by 77% | (Oruc and Unal, 2019) |
Antimicrobial peptides | |||||
EP | MWCNT | Medical devices |
E. coli P. aeruginosa S. aureus |
MWCNT/EP composites killed 97.6%, 91.5%, and 88.5% of E. coli, P. aeruginosa, and S. aureus, respectively | (Zhou and Qi, 2011) |
PLL and PGA | SWCNT | Medical devices |
E. coli S. epidermidis |
SWCNT/AMP films inactivated E. coli and S. epidermidis up to 90% | (Aslan et al., 2012) |
Nisin | MWCNT | Antimicrobial surfaces |
B. subtilis E. coli P. aeruginosa S. aureus |
MWCNT/nisin composites showed up to 7-fold higher antimicrobial activity than p-MWCNTs. Additionally, deposited films exhibited a 100-fold higher anti-biofilm activity than the p-MWCNT deposited film | (Qi et al., 2011) |
Enzymes | |||||
LSZ | SWCNT | Medical devices |
M. lysodeikticus S. aureus |
Coatings terminating in SWNT/LSZ layer exhibited an antimicrobial activity of 84% | (Nepal et al., 2008) |
Lysostaphin | MWCNT | Antimicrobial surfaces |
B. cereus E. coli MRSA S. epidermidis |
Enzyme-based composites were highly efficient in killing MRSA (> 99%) | (Pangule et al., 2010) |
Laccase | MWCNT | Antimicrobial surfaces |
B. anthracis B. cereus E. coli S. aureus |
The laccase-CNT films showed > 99% bactericidal activity against E. coli and S. aureus, and > 98% sporicidal activity against B. anthracis and B. cereus | (Grover et al., 2012) |
APT, antimicrobial photodynamic therapy; AMP, antimicrobial peptide; APT, amine-functionalized porphyrin; AZ, azithromycin; DTTC, 3,3′-diethylthiatricarbocyanine; EP, epsilon-polylysine; LSZ, lysozyme; MWCNT, multi-walled carbon nanotubes; PGA, poly(L-glutamic acid); PLL, polyelectrolytes poly(L-lysine); MRSA, MRSA, methicillin-resistant Staphylococcus aureus; NIR, near-infrared; SWCNT, single-walled carbon nanotubes.